Non-catalytic substrate-selective P38a-specific MAPK inhibitors with endothelial-stabilizing and anti-inflammatory activity, and methods of use thereof

摘要

Compounds that inhibit p38α MAPK protein, and methods of using the same, are provided for treating or preventing diseases such as cancer or inflammatory diseases.